山田 晶

Medicine & Life Sciences

1. Echocardiography 100%
2. Brain Natriuretic Peptide 56%
3. Heart Failure 52%
4. Mechanics 49%
5. Myocardial Infarction 43%
6. iodofiltic acid 41%
7. Heart Rate 36%
8. Stroke Volume 36%
9. Left Ventricular Dysfunction 30%
10. Exercise 29%
11. Myocardial Perfusion Imaging 28%
12. Right Ventricular Function 28%
13. Pulmonary Hypertension 27%
14. Left Ventricular Function 24%
15. Three-Dimensional Echocardiography 24%
16. Fatty Acid-Binding Proteins 22%
17. Mortality 22%
18. Transcatheter Aortic Valve Replacement 21%
19. fibrin fragment D 20%
20. Dilated Cardiomyopathy 20%
21. Hypertrophic Cardiomyopathy 20%
22. pentadecanoic acid 20%
23. Heart 18%
24. Coronary Artery Disease 18%
25. Subarachnoid Hemorrhage 18%
26. Heart Ventricles 18%
27. Athletes 16%
28. Arterial Pressure 16%
29. Troponin I 16%
30. Myocardium 14%
31. Magnetic Resonance Spectroscopy 14%
32. Intensive Care Units 14%
33. Acute Kidney Injury 14%
34. Serum 14%
35. Coronary Angiography 14%
36. technetium tc-99m tetrofosmin 13%
37. Nicorandil 12%
38. alternan 12%
39. Left Ventricular Hypertrophy 12%
40. 3-Iodobenzylguanidine 12%
41. Extracorporeal Shockwave Therapy 12%
42. Pulmonary Wedge Pressure 12%
43. Fenofibrate 11%
44. Lymphotoxin-alpha 11%
45. Endurance Training 11%
46. Stress Echocardiography 11%
47. Stable Angina 11%
48. Aortic Rupture 11%
49. Atrial Fibrillation 11%
50. KATP Channels 11%